Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BAMLANIVIMAB Cause Brain natriuretic peptide increased? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Brain natriuretic peptide increased have been filed in association with BAMLANIVIMAB. This represents 0.1% of all adverse event reports for BAMLANIVIMAB.

7
Reports of Brain natriuretic peptide increased with BAMLANIVIMAB
0.1%
of all BAMLANIVIMAB reports
1
Deaths
6
Hospitalizations

How Dangerous Is Brain natriuretic peptide increased From BAMLANIVIMAB?

Of the 7 reports, 1 (14.3%) resulted in death, 6 (85.7%) required hospitalization, and 2 (28.6%) were considered life-threatening.

Is Brain natriuretic peptide increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does BAMLANIVIMAB Cause?

Dyspnoea (833) Infusion related reaction (663) Pyrexia (641) Chills (453) Oxygen saturation decreased (448) Nausea (422) Covid-19 (346) Cough (342) Covid-19 pneumonia (313) Hypoxia (310)

What Other Drugs Cause Brain natriuretic peptide increased?

SACUBITRIL\VALSARTAN (252) MACITENTAN (192) TADALAFIL (176) ASPIRIN (157) SELEXIPAG (156) RIVAROXABAN (134) ROSUVASTATIN (133) TAMSULOSIN (131) CLOPIDOGREL BISULFATE (127) TREPROSTINIL (124)

Which BAMLANIVIMAB Alternatives Have Lower Brain natriuretic peptide increased Risk?

BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB BAMLANIVIMAB vs BARACLUDE BAMLANIVIMAB vs BARICITINIB BAMLANIVIMAB vs BARIUM BAMLANIVIMAB vs BARNIDIPINE

Related Pages

BAMLANIVIMAB Full Profile All Brain natriuretic peptide increased Reports All Drugs Causing Brain natriuretic peptide increased BAMLANIVIMAB Demographics